Methodological approaches in application of synthetic lethality screening towards anticancer therapy.

Methodological approaches in application of synthetic lethality screening towards anticancer therapy.
复制标题

DOI:
10.1038/sj.bjc.6605000
复制
发表时间:
2009-04-21
影响因子:
8.8
通讯作者:
Canaani, D.
Canaani, D.
中科院分区:
医学1区
文献类型:
--
作者:
Canaani, D.

文献摘要

参考文献

被引文献

相似文献

合成致死性概念的使用是选择性低毒抗癌药物开发的一个有前途的方向。大规模合成低分子化学文库的出现使得HTS能够在激活的癌基因或肿瘤抑制基因中寻找具有明确的人类癌症异常的协同致死化合物。在人类/小鼠肿瘤细胞中寻找合成致命化学物质在很大程度上得益于对相关信号和DNA修复途径的先验知识,从而允许对首选的潜在治疗靶点进行有根据的猜测。最新一代的人类/啮齿动物全基因组siRNA和shRNA表达文库,应该会进一步推动这种更有针对性的癌症药物发现方法。
A promising direction in the development of selective less toxic cancer drugs is the usage of synthetic lethality concept. The availability of large-scale synthetic low-molecular-weight chemical libraries has allowed HTS for compounds synergistic lethal with defined human cancer aberrations in activated oncogenes or tumour suppressor genes. The search for synthetic lethal chemicals in human/mouse tumour cells is greatly aided by a prior knowledge of relevant signalling and DNA repair pathways, allowing for educated guesses on the preferred potential therapeutic targets. The recent generation of human/rodents genome-wide siRNAs, and shRNA-expressing libraries, should further advance this more focused approach to cancer drug discovery.
DOI: 10.1073/pnas.171060098
发表时间: 2001-08-28
影响因子: 11.1
作者:
Podsypanina, K;Lee, RT;Parsons, R
通讯作者: Parsons, R
DOI: 10.1016/s1535-6108(02)00082-x
发表时间: 2002-07-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Fantin, VR;Berardi, MJ;Leder, P
通讯作者: Leder, P
DOI: 10.1016/j.chembiol.2006.01.010
发表时间: 2006-03-01
影响因子: --
作者:
Perlstein, EO;Ruderfer, DM;Schreiber, SL
通讯作者: Schreiber, SL
DOI: 10.1073/pnas.171076798
发表时间: 2001-08-28
影响因子: 11.1
作者:
Neshat, MS;Mellinghoff, IK;Sawyers, CL
通讯作者: Sawyers, CL
DOI: 10.1093/jnci/94.2.88
发表时间: 2002-01-16
影响因子: 10.3
作者:
Dunstan, HM;Ludlow, C;Lamb, JR
通讯作者: Lamb, JR